glp 1 drugs and alcohol consumption GLP-1 Trends: Retail Shopping, & More As more patients take GLP-1

New analysis of GLP-1 drugs suggests people who stopped using medications regained 60% of weight lost A new study, recently shared on Good Morning America , on life after weight loss drugs examined 48 studies that analyzed and predicted the outcomes of people who either had diabetes or were overweight or obese and took popular GLP-1 medications

The IMPACT MASH trial tested 1.2 mg and 1.8 mg doses over 24 weeks

But individual responses vary, and regular monitoring confirms your liver is responding well

In 2005, US Food and Drug Administration (FDA) approved exenatide for the treatment of type 2 DM

Bettadapura et al., 2024

Effect of Sodium-Glucose Cotransporter-2 Inhibitors on Aldosterone-to-Renin Ratio in Diabetic Patients With Hypertension: A Retrospective Observational Study